RÉSUMÉ
BACKGROUND: To evaluate the ability of the estimated plasma expression levels of genes of microRNA (MiR-) 146a and 155 to differentiate between samples of pregnant women suspected to be infected by T. gondii. 50 newly pregnant women who had at least one of the criteria of high risk for toxoplasma infection and 50 newly primigravida women free of these criteria gave blood samples for qualitative determination of serum toxoplasma antibodies and estimation of plasma expression levels of MiR-146a and 155 using the qRT-PCR. During the pregnancy course, the incidence of pregnancy complications was recorded. RESULTS: Twenty-six women were IgM-/IgG-, 17 women were IgM+/IgG- and 7 women were IgM+/IgG+. Thirty-two women had pregnancy complications with significantly lower incidence in IgM-/IgG- women. Plasma expression levels of MiR-146a and 155 were significantly higher in total patients compared to control levels and were significantly higher in samples of IgM+/IgG+ patients than in other samples. Statistical analyses defined a high plasma level of MiR-155 as the highly significant predictor for oncoming pregnancy complications and high levels of both microRNAs as predictors for the presence of toxoplasmosis despite seronegativity. Kaplan-Meier regression analysis defined increasing cumulative risk of having toxoplasmosis despite seronegativity with plasma levels of MiR-146a and MiR-155 of 1.2 and 3, respectively. CONCLUSION: The incidence of pregnancy complications is high, irrespective of the seronegativity of women at high risk of toxoplasmosis. Estimated plasma levels of MiR-155 might identify women liable to develop complications and differentiate seronegative women vulnerable to having T. gondii infection. TRIAL REGISTRATION: The study protocol was approved preliminarily by the Local Ethical Committee at Benha Faculty of Medicine. Before enrollment, the study protocol was discussed in detail with the study participants, and those accepted to participate in the study signed written fully informed consents. The final approval of the study protocol was obtained after the end of case collection and registered by RC: 5-11-2022.
Sujet(s)
Immunoglobuline M , microARN , Toxoplasma , Toxoplasmose , Humains , Femelle , Grossesse , microARN/sang , Toxoplasmose/sang , Adulte , Toxoplasma/immunologie , Toxoplasma/génétique , Immunoglobuline M/sang , Immunoglobuline G/sang , Complications parasitaires de la grossesse/sang , Anticorps antiprotozoaires/sang , Jeune adulteRÉSUMÉ
This study aims to investigate the relationship between toxoplasmosis and this pathway, which may be effective in the formation of epilepsy by acting through the HMGB1/RAGE/TLR4/NF-κB signalling pathway in patients with idiopathic epilepsy. In the study, four different experimental groups were formed by selecting Toxoplasma gondii IgG positive and negative patients with idiopathic epilepsy and healthy controls. Experimental groups were as follows: Group 1: Epilepsy+/Toxo- (E+, T-) (n = 10), Group 2: Epilepsy-/Toxo- (E-, T-) (n = 10), Group 3: Epilepsy-/Toxo+ (E-, T+) (n = 10), Group 4: Epilepsy+/Toxo+ (E+, T+) (n = 10). HMGB1, RAGE, TLR4, TLR1, TLR2, TLR3, IRAK1, IRAK2, IKBKB, IKBKG, BCL3, IL1ß, IL10, 1 L8 and TNFα mRNA expression levels in the HMGB/RAGE/TLR4/NF-κB signalling pathway were determined by quantitative simultaneous PCR (qRT-PCR) after collecting blood samples from all patients in the groups. Statistical analysis was performed by one-way ANOVA followed by LSD post-hoc tests, and p < 0.05 was considered to denote statistical significance. The gene expression levels of HMGB1, TLR4, IL10, IL1B, IL8, and TLR2 were significantly higher in the G1 group than in the other groups (p < 0.05). In the G3 group, RAGE and BCL3 gene expression levels were significantly higher than in the other groups (p < 0.05). In the G4 group, however, IRAK2, IKBKB, and IKBKG gene expression levels were significantly higher than in the other groups (p < 0.05). HMGB1, TLR4, IRAK2, IKBKB, IL10, IL1B, IL1B, and IL8 in this signalling pathway are highly expressed in epilepsy patients in G1 and seizures occur with the stimulation of excitatory mechanisms by acting through this pathway. The signalling pathway in epilepsy may be activated by HMGB1, TLR4, and TLR2, which are considered to increase the level of proinflammatory cytokines. In T. gondii, this pathway is activated by RAGE and BCL3.
Sujet(s)
Épilepsie , Protéine HMGB1 , Facteur de transcription NF-kappa B , Transduction du signal , Récepteur de type Toll-4 , Toxoplasmose , Humains , Récepteur de type Toll-4/métabolisme , Récepteur de type Toll-4/génétique , Protéine HMGB1/métabolisme , Protéine HMGB1/génétique , Facteur de transcription NF-kappa B/métabolisme , Facteur de transcription NF-kappa B/génétique , Mâle , Femelle , Épilepsie/métabolisme , Épilepsie/génétique , Épilepsie/parasitologie , Adulte , Toxoplasmose/parasitologie , Toxoplasmose/métabolisme , Toxoplasmose/complications , Toxoplasmose/sang , Toxoplasmose/génétique , Récepteur spécifique des produits finaux de glycosylation avancée/métabolisme , Récepteur spécifique des produits finaux de glycosylation avancée/génétique , Études cas-témoins , Jeune adulte , Adulte d'âge moyen , Antigènes néoplasiques , Mitogen-Activated Protein KinasesRÉSUMÉ
BACKGROUND: Toxoplasmosis is a zoonotic parasitic disease caused by Toxoplasma gondii (T. gondii). It has a wide host range and is capable of vertical transmission in pregnant women, which may lead to undesirable pregnancy outcomes such as congenital malformations, miscarriage, premature birth and stillbirth. This study investigated the seroprevalence of T. gondii infection among pregnant women attending the antenatal clinic at Namwala District Hospital in Southern Zambia. METHODS: This was a cross-sectional study where blood was collected, and the serum was tested for Toxoplasma IgG and IgM. A questionnaire was administered to participants on demographic characteristics and risk factors. Data were entered in Microsoft Excel and exported to STATA version 14 for analysis. RESULTS: A total of 401 women were enrolled in the study from 3 March to 5 August 2021. The seroprevalence of Toxoplasma IgG was 4.2% (n=17), while the seroprevalence of Toxoplasma IgM was 0.7% (n=3). The median age was 27 (IQR: 24-30) years, and a larger proportion had primary-level education (n=223, 55.6%). The majority (81.6%) of the women were married. None of the risk factors investigated in this study were significant for T. gondii infection. CONCLUSION: There was a low seroprevalence of T. gondii infection among pregnant women in the Namwala district of Southern Province, Zambia, and regular screening may not be warranted in this population. Continued research on toxoplasmosis is recommended to understand its epidemiology across Zambia.
Sujet(s)
Anticorps antiprotozoaires , Immunoglobuline M , Complications parasitaires de la grossesse , Toxoplasma , Toxoplasmose , Humains , Femelle , Zambie/épidémiologie , Études transversales , Études séroépidémiologiques , Adulte , Grossesse , Toxoplasmose/épidémiologie , Toxoplasmose/sang , Facteurs de risque , Toxoplasma/immunologie , Jeune adulte , Immunoglobuline M/sang , Anticorps antiprotozoaires/sang , Complications parasitaires de la grossesse/épidémiologie , Complications parasitaires de la grossesse/sang , Immunoglobuline G/sang , Prise en charge prénataleRÉSUMÉ
One of the many warm-blooded hosts that toxoplasmosis-causing intracellular protozoan parasite Toxoplasma gondii can infect is humans. Cytokines are crucial to stimulate an effective immune response against T. gondii. Interleukin-33 (IL-33) is a unique anti-inflammatory cytokine that suppresses the immune response. The levels of cytokine gene expression are regulated by genetics, and the genetic polymorphisms of these cytokines play a functional role in this process. Single nucleotide polymorphisms (SNPs) are prognostic indicators of illnesses. This study aimed to determine whether toxoplasmosis interacts with serum levels of IL-33 and its SNP in miscarriage women as well as whether serum levels and IL-33 gene expression are related in toxoplasmosis-positive miscarriage women. Two hundred blood samples from patients and controls were collected from AL-Alawiya Maternity Teaching Hospital and AL-Yarmouk Teaching Hospital in Baghdad, Iraq from 2021 to 2022 in order to evaluate the serum level of IL-33 using ELISA test. For the SNP of IL-33, the allelic high-resolution approach was utilized, and real time-PCR was performed to assess gene expression. The results showed that compared to healthy and pregnant women, recurrent miscarriage with toxoplasmosis and recurrent miscarriage women had lower IL-33 concentrations. Additionally, there were significant differences among healthy women, pregnant women, and women with repeated miscarriage who experienced toxoplasmosis. Furthermore, no differences between patients and controls were revealed by gene expression data. The results revealed that recurrent miscarriage, pregnancy, and healthy women all had a slightly higher amount of the IL-33 gene fold. Additionally, the SNP of IL-33 data demonstrated that there was no significant genetic relationship between patients and controls. Recurrent miscarriage women with toxoplasmosis have showed significant differences from pregnant women in the genotypes GG and AA as well as the alleles A and G. There were notable variations between recurrent miscarriage with and without toxoplasmosis in terms of the genotypes AA and AC. The genotypes GG, AA, and allele A in recurrent miscarriage women with toxoplasmosis and recurrent miscarriage women is a protective factor. Taking together, there was a statistically significant negative correlation between toxoplasmosis and IL-33 gene expression, which calls for more quantitative investigation in order to fully comprehend the interaction of mRNA and protein.
Sujet(s)
Avortements à répétition , Interleukine-33 , Polymorphisme de nucléotide simple , Toxoplasmose , Humains , Femelle , Interleukine-33/sang , Interleukine-33/génétique , Avortements à répétition/génétique , Avortements à répétition/sang , Avortements à répétition/parasitologie , Grossesse , Iraq , Adulte , Toxoplasmose/sang , Toxoplasmose/complications , Toxoplasmose/parasitologie , Expression des gènes , Études cas-témoins , Jeune adulte , Test ELISA , Toxoplasma/immunologie , Toxoplasma/génétique , Réaction de polymérisation en chaine en temps réel , Génotype , Complications parasitaires de la grossesse/sang , Complications parasitaires de la grossesse/parasitologie , Complications parasitaires de la grossesse/génétiqueRÉSUMÉ
BACKGROUND AND AIM: Immunity alterations have been observed in bipolar disorder (BD). However, whether serum positivity of antibodies to Toxoplasma gondii (T gondii), rubella, and cytomegalovirus (CMV) shared clinical relevance with BD, remains controversial. This study aimed to investigate this association. METHODS: Antibody seropositivity of IgM and IgG to T gondii, rubella virus, and CMV of females with BD and controls was extracted based on medical records from January 2018 to January 2023. Family history, type of BD, onset age, and psychotic symptom history were also collected. RESULTS: 585 individuals with BD and 800 healthy controls were involved. Individuals with BD revealed a lower positive rate of T gondii IgG in the 10-20 aged group (OR = 0.10), and a higher positive rate of rubella IgG in the 10-20 (OR = 5.44) and 20-30 aged group (OR = 3.15). BD with family history preferred a higher positive rate of T gondii IgG (OR = 24.00). Type-I BD owned a decreased positive rate of rubella IgG (OR = 0.37) and an elevated positive rate of CMV IgG (OR = 2.12) compared to type-II BD, while BD with early onset showed contrast results compared to BD without early onset (Rubella IgG, OR = 2.54; CMV IgG, OR = 0.26). BD with psychotic symptom history displayed a lower positive rate of rubella IgG (OR = 0.50). LIMITATIONS: Absence of male evidence and control of socioeconomic status and environmental exposure. CONCLUSIONS: Differential antibody seropositive rates of T gondii, rubella, and cytomegalovirus in BD were observed.
Sujet(s)
Anticorps antiprotozoaires , Anticorps antiviraux , Trouble bipolaire , Cytomegalovirus , Immunoglobuline G , Immunoglobuline M , Virus de la rubéole , Toxoplasma , Humains , Trouble bipolaire/immunologie , Trouble bipolaire/sang , Femelle , Toxoplasma/immunologie , Adulte , Virus de la rubéole/immunologie , Cytomegalovirus/immunologie , Études transversales , Anticorps antiviraux/sang , Jeune adulte , Immunoglobuline G/sang , Anticorps antiprotozoaires/sang , Adolescent , Adulte d'âge moyen , Immunoglobuline M/sang , Enfant , Toxoplasmose/immunologie , Toxoplasmose/sang , Rubéole/immunologie , Infections à cytomégalovirus/immunologieRÉSUMÉ
Leprosy is a chronic infectious disease caused by the bacillus Mycobacterium leprae. The disease may evolve for inflammatory reactions, reversal reaction (RR) and erythema nodosum leprosum (ENL), the major cause of irreversible neuropathy in leprosy, which occur in 1 in 3 people with leprosy, even with effective treatment of M. leprae. Leprosy remains persistently endemic in our region where it predominantly affects lowest socioeconomic conditions people, as Toxoplasma gondii infection in the municipality studied. Previously, we have shown T. gondii coinfection as a risk marker for leprosy, mainly in its severe form. This present study assessed whether T. gondii infection is also a risk factor for leprosy reactions and the predictive value of immunoglobulin production prior to development of leprosy reactions. Patients with leprosy (n = 180), co-infected or not with T. gondii, had their serum investigated for levels of IgA, IgE, IgG1, IgG2, IgG3 and IgG4 anti-PGL-1 by ELISA prior to development of leprosy reactions. The serologic prevalence for T. gondii infection was 87.7% in leprosy reaction patients reaching 90.9% in those with ENL. The leprosy reaction risk increased in T. gondii seropositive individuals was two-fold ([OR] = 2.366; 95% confidence interval [CI 95%]: 1.024-5.469) higher than those seronegative, and considering the risk of ENL, this increase was even more evident (OR = 6.753; 95% CI: 1.050-72.85) in coinfected individuals. When evaluated the prediction of anti-PGL-1 immunoglobulin levels for development of leprosy reactions in patients coinfected or not with T. gondii, only the increase IgE levels were associated to occurrence of reactional episodes of leprosy, specifically ENL type, in patients coinfected with T. gondii, compared to those not coinfected or no reaction. Thus, the immunomodulation in co-parasitism T. gondii-M. leprae suggest increased levels of IgE as a biomarker for early detection of these acute inflammatory episodes and thereby help prevent permanent neuropathy and disability in leprosy patients.
Sujet(s)
Érythème noueux , Immunoglobuline E , Toxoplasma , Toxoplasmose , Humains , Toxoplasmose/sang , Toxoplasmose/complications , Toxoplasmose/immunologie , Toxoplasmose/épidémiologie , Érythème noueux/immunologie , Érythème noueux/épidémiologie , Érythème noueux/sang , Femelle , Mâle , Adulte , Immunoglobuline E/sang , Adulte d'âge moyen , Toxoplasma/immunologie , Co-infection/immunologie , Co-infection/parasitologie , Mycobacterium leprae/immunologie , Jeune adulte , Adolescent , Facteurs de risque , Sujet âgé , Lèpre lépromateuse/immunologie , Lèpre lépromateuse/complications , Lèpre lépromateuse/sang , Lèpre lépromateuse/épidémiologieRÉSUMÉ
We aimed to assess salivary and seroprevalence of Toxoplasma immunoglobulins in risky populations and evaluate drug docking targeting TgERP. A cross-sectional study was conducted in Alexandria University hospitals' outpatient clinics. 192 participants were enrolled from September 2022 to November 2023. Anti-Toxoplasma IgG and IgM were determined in serum and saliva by ELISA. An in-Silico study examined TgERP's protein-protein interactions (PPIs) with pro-inflammatory cytokine receptors, anti-inflammatory cytokine, cell cycle progression regulatory proteins, a proliferation marker, and nuclear envelope integrity-related protein Lamin B1. Our findings revealed that anti-T. gondii IgG were detected in serum (66.1%) and saliva (54.7%), with 2.1% of both samples were positive for IgM. Salivary IgG had 75.59% sensitivity, 86.15% specificity, 91.40% PPV, 64.40% NPP, 79.17% accuracy and fair agreement with serum IgG. On the other hand, the sensitivity, specificity, PPV, NPV, and accuracy in detecting salivary IgM were 75.0%, 99.47%, 75.0%, 99.47%, and 98.96%. AUC 0.859 indicates good discriminatory power. Examined synthetic drugs and natural products can target specific amino acids residues of TgERP that lie at the same binding interface with LB1 and Ki67, subsequently, hindering their interaction. Hence, salivary samples can be a promising diagnostic approach. The studied drugs can counteract the pro-inflammatory action of TgERP.
Sujet(s)
Immunoglobuline G , Immunoglobuline M , Inflammation , Salive , Toxoplasma , Toxoplasmose , Humains , Mâle , Salive/métabolisme , Femelle , Adulte , Toxoplasmose/traitement médicamenteux , Toxoplasmose/sang , Toxoplasmose/métabolisme , Toxoplasmose/parasitologie , Immunoglobuline G/sang , Études transversales , Inflammation/métabolisme , Immunoglobuline M/sang , Immunoglobuline M/métabolisme , Adulte d'âge moyen , Jeune adulte , Anticorps antiprotozoaires/immunologie , Simulation numérique , Études séroépidémiologiques , Adolescent , Simulation de docking moléculaireRÉSUMÉ
Introduction: Depressive syndrome (DS) is a common complication during pregnancy and the postpartum period, and is triggered by multiple organic/genetic and environmental factors. Clinical and biochemical follow-up is essential for the early diagnosis and prognosis of DS. The protozoan Toxoplasma gondii causes infectious damage to the fetus during parasite primary-infection. However, in long-term infections, pregnant women develop immune protection to protect the fetus, although they remain susceptible to pathological or inflammatory effects induced by T. gondii. This study aimed to investigate plasma inflammatory biomarkers in pregnant women seropositive and seronegative for T. gondii, with diagnoses of minor and moderate/severe DS. Methods: Pregnant women (n=45; age=18-39 years) were recruited during prenatal care at health centers in Ouro Preto, Minas Gerais, Brazil. Participants were asked to complete a socio-demographic questionnaire to be submitted to well-standardized DS scale calculators (Beck Depression Inventory Questionnaire, Edinburgh Postnatal Depression Scale, and Major Depressive Episode Module). Additionally, 4 mL of blood was collected for plasma neuroserpin, CCL2, IL-17A, and IL-33 analysis. Results: Pregnant volunteers with chronic T. gondii contact were all IgG+ (44%; n=21) and exhibited increased plasma IL-33, IL-17A, and neuroserpin levels, but not CCL2, compared to uninfected pregnant women. Using Beck's depression inventory, we observed an increase in plasma IL-17A and IL-33 in women with T. gondii infeCction diagnosed with mild DS, whereas neuroserpin was associated with minor and moderate/severe DS. Discussion: Our data suggest a close relationship between DS in pregnant women with chronic T. gondii infection and neurological conditions, which may be partially mediated by plasma neuroserpin, IL-33, and IL-17A levels.
Sujet(s)
Marqueurs biologiques , Interleukine-17 , Interleukine-33 , Toxoplasma , Toxoplasmose , Humains , Femelle , Grossesse , Interleukine-17/sang , Adulte , Toxoplasmose/sang , Toxoplasmose/diagnostic , Toxoplasmose/immunologie , Toxoplasmose/psychologie , Marqueurs biologiques/sang , Interleukine-33/sang , Jeune adulte , Toxoplasma/immunologie , Adolescent , Complications parasitaires de la grossesse/sang , Complications parasitaires de la grossesse/immunologie , Complications parasitaires de la grossesse/diagnostic , Dépression/sang , Dépression/immunologie , Dépression/diagnosticRÉSUMÉ
Toxoplasma gondii, a parasite infecting around one-third of the global population, has been linked to neurological disorders like schizophrenia. Abnormal dopamine levels are linked to the pathophysiology of schizophrenia, but their association remains unclear. This study aimed to investigate the relationship between T. gondii seroprevalence and dopamine serum levels in schizophrenic patients in Egypt. This case-control study included 93 patients diagnosed with schizophrenia and 93 individuals as controls. T. gondii seroprevalence was determined using an enzyme-linked immunosorbent assay (ELISA). Dopamine serum levels were measured using ELISA. Sociodemographic and clinical characteristics were also collected. The study found a higher prevalence of T. gondii IgG antibodies in patients with schizophrenia (68 %) compared to controls (46.2 %). Contact with cats, sausage consumption, and undercooked meat were identified as possible risk factors associated with T. gondii infection. The mean level of serum dopamine was significantly (P < 0.001) higher in patients with schizophrenia (115.3 Pg/ml ±31.8) compared to the control group (75.02 Pg/ml ±26.5). The study found that schizophrenic patients with T. gondii seropositivity had significantly higher dopamine serum levels (mean=145.2 ± 32.1 pg/ml) than those without T. gondii seropositivity (mean=122.5 ± 29.7 pg/ml) (p = 0.001). Logistic regression analysis revealed that T. gondii seropositivity was a significant predictor of increased dopamine serum levels in schizophrenic patients (odds ratio=3.4, 95 % confidence interval=1.8-6.4, p < 0.001). The study suggests that T. gondii seroprevalence may increase dopamine serum levels in Egyptian schizophrenic patients, potentially contributing to dopamine dysregulation in schizophrenia, but further research is needed to confirm these findings and investigate the underlying mechanisms.
Sujet(s)
Anticorps antiprotozoaires , Dopamine , Schizophrénie , Toxoplasmose , Humains , Schizophrénie/sang , Schizophrénie/épidémiologie , Schizophrénie/parasitologie , Égypte/épidémiologie , Toxoplasmose/épidémiologie , Toxoplasmose/sang , Mâle , Femelle , Dopamine/sang , Études cas-témoins , Adulte , Anticorps antiprotozoaires/sang , Études séroépidémiologiques , Adulte d'âge moyen , Immunoglobuline G/sang , Toxoplasma/immunologie , Test ELISA , Jeune adulte , Facteurs de risque , AnimauxRÉSUMÉ
Toxoplasma gondii is a neurotropic protozoan parasite that affects neuronal processing in the brain. This study aimed to investigate the prevalence of T. gondii infection in psychiatric disorder patients. We also investigated the potential association between sociodemographic, clinical manifestation, and behavior of Toxoplasma-seropositive patients with psychiatric disorders. Commercial ELISAs (IgG, IgM, and IgG avidity) using serum and PCR using buffy coat were performed on samples from 54 individuals in each of the following groups: patients diagnosed with depressive disorder, bipolar disorder, and schizophrenia, as well as psychiatrically healthy subjects (control group). They were recruited from the Hospital Universiti Sains Malaysia in Kelantan, Malaysia. Of 54 patients with depressive disorder, 24/54 (44.4 %) were seropositive for IgG, and four (16.7 %) were IgG+/IgM+. Among the latter, a high avidity index indicating a past infection was observed in half of the samples (50.0 %), and the other half (50.0 %) showed a low avidity index, indicating a possible recent infection. Meanwhile, 30/54 (55.6 %) patients with bipolar disorder were seropositive for IgG+, five (16.7 %) were IgG+/IgM+, and four of them had a high avidity index, and one had a low avidity index. Patients with schizophrenia showed 29/54 (53.7 %) seropositive for IgG, two of them (6.9 %) were IgG+/IgM+; one of latter had a high avidity index, and one had a low avidity index. Of 54 people in the control group, 37.0 % (20/54) were seropositive for T. gondii IgG antibodies. However, no significant difference was observed in seroprevalence between the control group and each patient group. No PCR-positive results were documented. A Chi-Square and multiple logistic regression showed that age (p = 0.031), close contact with cats/pets (p = 0.033) and contact with soil (p = 0.012) were significantly associated with Toxoplasma seropositivity in patients with psychiatric disorders. Additional research is needed to elucidate the causal relationships and underlying mechanisms.
Sujet(s)
Anticorps antiprotozoaires , Immunoglobuline G , Immunoglobuline M , Toxoplasma , Toxoplasmose , Humains , Toxoplasmose/épidémiologie , Toxoplasmose/complications , Toxoplasmose/sang , Malaisie/épidémiologie , Études séroépidémiologiques , Mâle , Femelle , Adulte , Anticorps antiprotozoaires/sang , Toxoplasma/immunologie , Adulte d'âge moyen , Immunoglobuline G/sang , Immunoglobuline M/sang , Jeune adulte , Troubles mentaux/épidémiologie , Schizophrénie/épidémiologie , Schizophrénie/complications , Affinité des anticorps , Test ELISA , Facteurs socioéconomiques , Sujet âgé , Adolescent , Trouble bipolaire/épidémiologie , Trouble bipolaire/complications , Trouble bipolaire/sang , Réaction de polymérisation en chaîneRÉSUMÉ
BACKGROUND: Accumulating evidence suggests that latent infection with Toxoplasma gondii (T. gondii) is associated with a variety of neuropsychiatric and behavioral conditions. This research aims to explore the potential correlation between T. gondii antibody positivity and neuropsychiatric disorders through a comprehensive prospective cohort study. METHODS: The cohort study utilized the UK Biobank database to recruit 8814 individuals with no prior diagnosis of neuropsychiatric disorders. Cox proportional hazards models were employed to investigate the associations between T. gondii P22 antibody seropositivity (P22+) and the development of various types of neuropsychiatric disorders. RESULTS: Of the population, 14.65 % tested positive for T. gondii P22 antibody. The presence of T. gondii P22 antibody showed a slight inverse association with epilepsy (HR: 0.28; 95 % CI: 0.10-0.77), while it was positively associated with an increased risk of developing anxiety disorders (HR: 1.38; 95 % CI: 1.04-1.83). LIMITATIONS: The study sample consisted mostly of white British individuals aged 40 to 69 years old. Although we adjusted for potential confounders, there may be other unmeasured and residual confounding factors that could have influenced our reported associations. CONCLUSIONS: The findings suggested an increased risk of anxiety and potential evidence of epilepsy associated with T. gondii P22+. However, our analysis did not reveal an increased risk of several other neuropsychiatric conditions including Alzheimer's disease, dementia, substance abuse disorders, depression, and neurodegenerative disorders, associated with P22 antibody seropositivity.
Sujet(s)
Toxoplasma , Toxoplasmose , Humains , Femelle , Mâle , Adulte d'âge moyen , Toxoplasma/immunologie , Adulte , Sujet âgé , Toxoplasmose/immunologie , Toxoplasmose/épidémiologie , Toxoplasmose/sang , Royaume-Uni , Études prospectives , Épilepsie/immunologie , Anticorps antiprotozoaires/sang , Troubles anxieux/immunologie , Troubles anxieux/épidémiologie , Modèles des risques proportionnels , Études de cohortes , Infection latente/immunologie , Anxiété/immunologie , Anxiété/épidémiologieSujet(s)
Pneumopathie infectieuse , Toxoplasma , Toxoplasmose , Zoonoses , Femelle , Humains , Bronchoscopie , Acides nucléiques acellulaires/sang , Infections communautaires/sang , Infections communautaires/diagnostic , Infections communautaires/étiologie , Infections communautaires/thérapie , ADN des protozoaires/sang , ADN des protozoaires/isolement et purification , Hypoxie/sang , Hypoxie/diagnostic , Hypoxie/étiologie , Hypoxie/thérapie , Immunocompétence , Recueil de l'anamnèse , Pneumopathie infectieuse/sang , Pneumopathie infectieuse/diagnostic , Pneumopathie infectieuse/étiologie , Pneumopathie infectieuse/thérapie , Insuffisance respiratoire/sang , Insuffisance respiratoire/diagnostic , Insuffisance respiratoire/thérapie , Toxoplasma/isolement et purification , Toxoplasmose/sang , Toxoplasmose/diagnostic , Toxoplasmose/étiologie , Toxoplasmose/thérapie , Résultat thérapeutique , Zoonoses/sang , Zoonoses/diagnostic , Zoonoses/étiologie , Zoonoses/thérapie , Cervidae/parasitologieRÉSUMÉ
BACKGROUND: Toxoplasma gondii (T. gondii) is a worldwide distributed protozoan parasite which has infected a wide range of warm-blooded animals and humans. The most common form of T. gondii infection is asymptomatic (latent); nevertheless, latent toxoplasmosis can induce various alterations of sex hormones, especially testosterone, in infected humans and animals. On the other hand, testosterone is involved in behavioral traits and reproductive functions in both sexes. Hence, the purpose of this systematic review is to summarize the available evidence regarding the association between T. gondii infection and testosterone alteration. METHODS: In the setting of a systematic review, an electronic search (any date to 10 January 2023) without language restrictions was performed using Science Direct, Web of Science, PubMed, Scopus, and Google Scholar. The PRISMA guidelines were followed. Following the initial search, a total of 12,306 titles and abstracts were screened initially; 12,281 were excluded due to the lack of eligibility criteria or duplication. Finally, 24 articles met the included criteria. A mean±standard deviation (SD) was calculated to assess the difference of testosterone between T. gondii positive and T. gondii negative humans. The possibility of publication bias was assessed using Egger's regression. P-value < 0.05 was considered statistically significant. RESULTS: This systematic review identified 24 articles (18 studies in humans and six studies in animals). Most human studies (13 out of 19) reported an increased level of testosterone following latent toxoplasmosis in males, while three studies reported decreased levels and two studies reported an insignificant change. Eleven articles (seven datasets in males and seven datasets in females) were eligible to be included in the data synthesis. Based on the random-effects model, the pooled mean± SD of testosterone in T. gondii positive than T. gondii negative was increased by 0.73 and 0.55 units in males and females, respectively. The Egger's regression did not detect a statistically significant publication bias in males and females (p = value = 0.95 and 0.71), respectively. Three studies in male animals (rats, mice, and spotted hyenas) and two studies in female animals (mice and spotted hyenas) reported a decline in testosterone in infected compared with non-infected animals. While, one study in female rats reported no significant changes of testosterone in infected than non-infected animals. Moreover, two studies in male rats reported an increased level of testosterone in infected than non-infected animals. CONCLUSIONS: This study provides new insights about the association between T. gondii infection and testosterone alteration and identifies relevant data gaps that can inform and encourage further studies. The consequence of increased testosterone levels following T. gondii infection could partly be associated with increased sexual behavior and sexual transmission of the parasite. On the other hand, declining testosterone levels following T. gondii infection may be associated with male reproductive impairments, which were observed in T. gondii-infected humans and animals. Furthermore, these findings suggest the great need for more epidemiological and experimental investigations in depth to understand the relationship between T. gondii infection and testosterone alteration alongside with future consequences of testosterone alteration.
Sujet(s)
Testostérone , Toxoplasma , Toxoplasmose , Testostérone/sang , Toxoplasmose/parasitologie , Toxoplasmose/sang , Humains , Animaux , Mâle , Femelle , SourisRÉSUMÉ
Gestational diabetes (GDM), the onset of any degree of glucose intolerance during pregnancy, increases a wide range of adverse health outcomes for both the mother and the fetus. The aim of the present study was to evaluate the association of Toxoplasma gondii infection with GDM in a case-control study with regard to the levels of leptin and tumor necrosis factor alpha (TNF-α) as two inflammatory biomarkers. Fifty-one pregnant diabetic cases and 109 controls were selected from a prenatal care clinic of a general hospital in Shiraz, southern Iran during July-November 2020. Cases and controls were similar in age, gestational age and number of parturitions. The presence of IgG antibodies against T. gondii, and serum concentrations of leptin and TNF-α were determined by ELISA. Anti-Toxoplasma antibodies were detected in 25 subjects (15.6 %, 95 % CI: 9.9-21.3). Nine (18 %) diabetic cases were infected with Toxoplasma compared to 16 (15 %) healthy controls (P = 0.63). Level of leptin was higher (P = 0.07) while TNF-α was lower in diabetic cases compared to healthy controls (P = 0.08). When subjects were classified according to the combination of GDM and T. gondii, leptin was significantly lower in healthy (non-diabetic, non-infected) subjects compared to diabetics (P = 0.026), and TNF-α was higher in healthy subjects compared to Toxoplasma-infected diabetics (P = 0.032). These findings can be interpreted as both comorbidities being individually associated with increasing serum leptin and decreasing TNF-α concentrations, with modifying effects on each other. The present study opens a new perspective on GDM and its complex pathophysiological mechanism. Future research in this area is needed to better understand the underlying pathway for the development of GDM and the role of T. gondii and inflammatory biomarkers.
Sujet(s)
Diabète gestationnel , Leptine , Toxoplasma , Toxoplasmose , Facteur de nécrose tumorale alpha , Humains , Diabète gestationnel/sang , Diabète gestationnel/parasitologie , Diabète gestationnel/épidémiologie , Femelle , Grossesse , Facteur de nécrose tumorale alpha/sang , Leptine/sang , Toxoplasmose/sang , Toxoplasmose/épidémiologie , Adulte , Études cas-témoins , Toxoplasma/immunologie , Iran/épidémiologie , Jeune adulte , Marqueurs biologiques/sang , Anticorps antiprotozoaires/sang , Immunoglobuline G/sangRÉSUMÉ
Toxoplasma gondii is a paradigmatic zoonotic parasite from the One Health perspective, since it is broadly distributed and virtually infects all warm-blooded species. A wide variety of serological techniques have been developed to detect T. gondii infection in humans and animals. Our aim was to describe and compare the main characteristics of these serological tests and validation processes and to critically analyze whether these tests meet the standards required to ensure an accurate serological diagnosis. The current systematic review and meta-analysis included 134 studies that were published from 2013 to 2023. QUADAS 2 tool was used to evaluate the quality of the included studies. A total of 52 variables related to the characteristics of the techniques and analytical and diagnostic validation parameters were studied. A wider panel of tests was developed for humans, including techniques exclusively developed for humans that involve costly equipment and the measurement of different Ig isotypes that are considered biomarkers of congenital toxoplasmosis. Studies conducted in humans frequently employed commercial techniques as reference tests, measured different immunoglobulin isotypes with a predominance for IgG (>50%) and discriminated between acute and chronic infections. In animals, the most commonly used reference techniques were in-house tests, which almost exclusively detected IgG. Common limitations identified in a large number of studies were some misunderstandings of the terms "gold standard" and "reference test" and the absence of information about the negative and positive control sera used or the exact cutoff employed, which were independent of the quality of the study. There is a lack of analytical validation, with few evaluations of cross-reactivity with other pathogens. Diagnostic odds ratio values showed that indirect ELISA based on native or chimeric antigens performed better than other tests. The reproducibility of serological test results in both humans and animals is not guaranteed due to a lack of relevant information and analytical validation. Thus, several key issues should be considered in the future, including interlaboratory ring trials.
Sujet(s)
Anticorps antiprotozoaires , Tests sérologiques , Toxoplasma , Toxoplasmose animale , Toxoplasmose , Animaux , Humains , Anticorps antiprotozoaires/sang , Reproductibilité des résultats , Tests sérologiques/médecine vétérinaire , Tests sérologiques/normes , Tests sérologiques/méthodes , Toxoplasma/immunologie , Toxoplasmose/diagnostic , Toxoplasmose/immunologie , Toxoplasmose/sang , Toxoplasmose animale/diagnostic , Toxoplasmose animale/immunologie , Toxoplasmose animale/sangRÉSUMÉ
BACKGROUND: Globally distributed with variable prevalence depending on geography, toxoplasmosis is a zoonosis caused by an obligate intracellular protozoan parasite, Toxoplasma gondii. This disease is usually benign but poses a risk for immunocompromised people and for newborns of mothers with a primary infection during pregnancy because of the risk of congenital toxoplasmosis (CT). CT can cause severe damage to fetuses-newborns. To our knowledge, no study has been conducted in sub-Saharan Africa on toxoplasmosis seroprevalence, seroconversion and CT in a large longitudinal cohort and furthermore, no observation has been made of potential relationships with malaria. METHODS: We performed a retrospective toxoplasmosis serological study using available samples from a large cohort of 1,037 pregnant women who were enrolled in a malaria follow-up during the 2008-2010 period in a rural area in Benin. We also used some existing data to investigate potential relationships between the maternal toxoplasmosis serological status and recorded malaria infections. RESULTS: Toxoplasmosis seroprevalence, seroconversion and CT rates were 52.6%, 3.4% and 0.2%, respectively, reflecting the population situation of toxoplasmosis, without targeted medical intervention. The education level influences the toxoplasmosis serological status of women, with women with little or no formal education have greater immunity than others. Surprisingly, toxoplasmosis seropositive pregnant women tended to present lower malaria infection during pregnancy (number) or at delivery (presence) and to have lower IgG levels to Plasmodium falciparum Apical Membrane Antigen 1, compared to toxoplasmosis seronegative women. CONCLUSIONS: The high toxoplasmosis seroprevalence indicates that prevention against this parasite remains important to deploy and must be accessible and understandable to and for all individuals (educated and non-educated). A potential protective role against malaria conferred by a preexisting toxoplasmosis infection needs to be explored more precisely to examine the environmental, parasitic and/or immune aspects.
Sujet(s)
Anticorps antiprotozoaires/sang , Paludisme à Plasmodium falciparum/épidémiologie , Plasmodium falciparum/isolement et purification , Complications parasitaires de la grossesse/épidémiologie , Femmes enceintes , Toxoplasma/isolement et purification , Toxoplasmose/épidémiologie , Adolescent , Adulte , Anticorps antiprotozoaires/immunologie , Bénin/épidémiologie , Femelle , Humains , Nouveau-né , Paludisme à Plasmodium falciparum/sang , Paludisme à Plasmodium falciparum/parasitologie , Grossesse , Complications parasitaires de la grossesse/parasitologie , Études rétrospectives , Études séroépidémiologiques , Toxoplasmose/sang , Toxoplasmose/parasitologie , Jeune adulteRÉSUMÉ
The aim of the study was to describe the pregnancy outcome of a large cohort of women with toxoplasmosis seroconversion in pregnancy and to investigate the relation between maternal lymphadenopathy and risk of congenital toxoplasmosis (CT). This was a retrospective study involving women with confirmed toxoplasmosis seroconversion in pregnancy between 2001 and 2017. Women were clinically evaluated for lymphadenopathy and classified as follows: lymphadenopathy absent (L-) or lymphadenopathy present (L+). The mothers were treated and followed-up according to local protocol, and neonates were monitored at least for 1 year in order to diagnose CT. A total of 218 women (one twin pregnancy) were included in the analysis. Pregnancy outcome was as follows: 149 (68%) of children not infected, 62 (28.3%) infected, 4 (1.8%) first trimester termination of pregnancy, 2 (0.9%) first trimester miscarriages, and 3 (1.4%) stillbirths (of which one already counted in the infected cohort). 13.8% of women were L+ , and they were nearly three times more likely to have a child with CT compared to L- women (aOR, 2.90; 95%CI, 1.28-6.58). Moreover, the result was still statistically significant when the analysis was restricted to 81 children whose mothers were clinically examined and received treatment within 5 weeks from estimated time of infection. In conclusion, there is a positive association between L+ status in pregnant women, and risk of CT also confirmed when restricting the analysis to women with early diagnosis of seroconversion and treatment. This data could be very useful in counselling pregnant women with toxoplasmosis seroconversion and lead to direct a more specific therapeutic and diagnostic protocol.
Sujet(s)
Anticorps antiprotozoaires/sang , Maladies néonatales/diagnostic , Lymphadénopathie/sang , Complications infectieuses de la grossesse/sang , Effets différés de l'exposition prénatale à des facteurs de risque/diagnostic , Toxoplasmose congénitale/diagnostic , Toxoplasmose/sang , Adulte , Femelle , Humains , Nourrisson , Nouveau-né , Maladies néonatales/parasitologie , Transmission verticale de maladie infectieuse , Lymphadénopathie/diagnostic , Lymphadénopathie/parasitologie , Mâle , Grossesse , Complications infectieuses de la grossesse/diagnostic , Complications infectieuses de la grossesse/parasitologie , Issue de la grossesse , Effets différés de l'exposition prénatale à des facteurs de risque/parasitologie , Études rétrospectives , Séroconversion , Toxoplasmose/diagnostic , Toxoplasmose/parasitologie , Toxoplasmose/transmission , Toxoplasmose congénitale/parasitologie , Jeune adulteRÉSUMÉ
<b>Background and Objective:</b> In recent years, respiratory tract viral infections have caused many pandemics that impact the whole world. To investigate the seropositivity of <i>Toxoplasma gondii</i>, rubella, CMV, HSV-1 and group A <i>Streptococcus</i> in recovered COVID-19 patients and correlate these findings with vitamin D levels. <b>Materials and Methods:</b> A total of 417 COVID-19 patients with diarrhoea were enrolled in this study. Vitamin D and seroprevalence for <i>Toxoplasma gondii</i>, rubella, CMV, HSV-1 and group A <i>Streptococcus</i> were evaluated and correlated. <b>Results:</b> It was found that recent infection in COVID-19 patients with HSV-1, rubella, <i>Toxoplasma</i> and CMV, respectively. IgG was detected indicating the development of adaptive immunity with all microbes. <b>Conclusion:</b> Current study detected a correlation between vitamin D levels and HSV-1 and no correlation between this infection and vitamin D deficiency with the other microbes.
Sujet(s)
Dépistage sérologique de la COVID-19 , COVID-19/diagnostic , Calcifédiol/sang , Herpès/diagnostic , Herpèsvirus humain de type 1/immunologie , Immunoglobuline G/sang , Carence en vitamine D/diagnostic , Immunité acquise , Adulte , Marqueurs biologiques/sang , COVID-19/sang , COVID-19/épidémiologie , COVID-19/immunologie , Cytomegalovirus/immunologie , Infections à cytomégalovirus/sang , Infections à cytomégalovirus/diagnostic , Infections à cytomégalovirus/épidémiologie , Infections à cytomégalovirus/immunologie , Femelle , Herpès/sang , Herpès/épidémiologie , Herpès/immunologie , Humains , Mâle , Adulte d'âge moyen , Valeur prédictive des tests , Prévalence , Rubéole/sang , Rubéole/diagnostic , Rubéole/épidémiologie , Rubéole/immunologie , Virus de la rubéole/immunologie , Arabie saoudite/épidémiologie , Études séroépidémiologiques , Infections à streptocoques/sang , Infections à streptocoques/diagnostic , Infections à streptocoques/épidémiologie , Infections à streptocoques/immunologie , Streptococcus/immunologie , Toxoplasma/immunologie , Toxoplasmose/sang , Toxoplasmose/diagnostic , Toxoplasmose/épidémiologie , Toxoplasmose/immunologie , Carence en vitamine D/sang , Carence en vitamine D/épidémiologieRÉSUMÉ
The burden of infections on an individual and public health is profound. Many observational studies have shown a link between infections and the pathogenesis of disease; however a greater understanding of the role of host genetics is essential. Children from the longitudinal birth cohort, the Avon Longitudinal Study of Parents and Children, had 14 antibodies measured in plasma at age 7: Alpha-casein protein, beta-casein protein, cytomegalovirus, Epstein-Barr virus, feline herpes virus, Helicobacter pylori, herpes simplex virus 1, influenza virus subtype H1N1, influenza virus subtype H3N2, measles virus, Saccharomyces cerevisiae, Theiler's virus, Toxoplasma gondii, and SAG1 protein domain, a surface antigen of Toxoplasma gondii measured for greater precision. We performed genome-wide association analyses of antibody levels against these 14 infections (N = 357 - 5010) and identified three genome-wide signals (P < 5×10-8), two associated with measles virus antibodies and one with Toxoplasma gondii antibodies. In an association analysis focused on the human leukocyte antigen (HLA) region of the genome, we further detected 15 HLA alleles at a two-digit resolution and 23 HLA alleles at a four-digit resolution associated with five antibodies, with eight HLA alleles associated with Epstein-Barr virus antibodies showing strong evidence of replication in UK Biobank. We discuss how our findings from antibody levels complement other studies using self-reported phenotypes in understanding the architecture of host genetics related to infections.
Sujet(s)
Infections bactériennes/génétique , Toxoplasmose/génétique , Maladies virales/génétique , Adolescent , Anticorps antibactériens/sang , Anticorps antiprotozoaires/sang , Anticorps antiviraux/sang , Antigènes de protozoaire/génétique , Antigènes de protozoaire/immunologie , Bactéries/immunologie , Infections bactériennes/sang , Infections bactériennes/immunologie , Caséines/génétique , Caséines/immunologie , Enfant , Étude d'association pangénomique , Antigènes HLA/génétique , Humains , Études longitudinales , Polymorphisme de nucléotide simple , Protéines de protozoaire/génétique , Protéines de protozoaire/immunologie , Toxoplasma/immunologie , Toxoplasmose/sang , Toxoplasmose/immunologie , Maladies virales/sang , Maladies virales/immunologie , Virus/immunologieRÉSUMÉ
Infection with Toxoplasma gondii (T. gondii) during the pregnant period and its potentially miserable outcomes for the fetus, newborn, and even adult offspring continuously occur worldwide. People acquire infection through the consumption of infected and undercooked meat or contaminated food or water. T. gondii infection in pregnant women primarily during the gestation causes microcephaly, mental and psychomotor retardation, or death. Abnormal pregnancy outcomes are mainly associated with regulatory T cell (Treg) dysfunction. Tregs, a special subpopulation of T cells, function as a vital regulator in maintaining immune homeostasis. Tregs exert a critical effect on forming and maintaining maternal-fetal tolerance and promoting fetal development during the pregnancy period. Forkhead box P3 (Foxp3), a significant functional factor of Tregs, determines the status of Tregs. In this review, we summarize the effects of T. gondii infection on host Tregs and its critical transcriptional factor, Foxp3.